tm logo
ZILBRYSQ
Live/Registered
REGISTERED

on 13 Feb 2024

Last Applicant/ Owned by

87 Cambridge Park Drive

Cambridge

MA

02140

Serial Number

90286947 filed on 29th Oct 2020

Registration Number

7305051 registered on 13th Feb 2024

in the Principal Register

Correspondent Address

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.

1025 Connecticut Avenue, NW, Suite 500

Washington, DC 20036

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ZILBRYSQ

The color(s) blue, orange, and red is/are claimed as a feature of the mark. Pharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis The mark consists of the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending a Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, for human use, for the prevention and treatment of myasthenia gravis


First Use Date in General

03rd Jan 2024

First Use Date in Commerce

03rd Jan 2024

Mark Details


Serial Number

No 90286947

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TM21-0219

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q".

Legal History


Show more

Status DateAction Taken
13th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024REGISTERED-PRINCIPAL REGISTER
10th Jan 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09th Jan 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09th Jan 2024STATEMENT OF USE PROCESSING COMPLETE
08th Jan 2024TEAS STATEMENT OF USE RECEIVED
08th Jan 2024USE AMENDMENT FILED
29th Nov 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Nov 2023SOU EXTENSION 5 GRANTED
28th Nov 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL